Answers are grounded in this paper and cite their sources.
Machine learning study demonstrates accurate cancer phenotype prediction from unannotated single-cell transcriptomes, highlighting a scalable approach to dissect tumor heterogeneity.
Single-cell sequencing offers profound insights into tumor complexity. However, reliably linking individual cellular profiles to overall sample-level phenotypes remains computationally challenging, particularly when cell-specific annotations are absent. This disconnect limits the technology’s utility in studying underlying tumor mechanisms. Here we show how scTransMIL, an artificial intelligence framework, bridges this gap. By conceptualizing a biological sample as a collection of individual cells, scTransMIL employs a transformer-based multi-instance learning approach to directly connect single-cell transcriptomic profiles with overarching sample-level labels. We demonstrate that scTransMIL accurately predicts sample-level cancer phenotypes, including the tissue-of-origin for metastatic tumors. At cellular resolution, it robustly identifies tumor-associated cell populations and maps biological progression trajectories using only minimal sample-level annotations. Furthermore, the model’s attention mechanisms facilitate full-transcriptome biomarker discovery. By systematically integrating molecular and cellular scales with broader phenotypic states, our approach provides a computational tool to dissect tumor heterogeneity and advance fundamental cancer biology. Reliably linking patient-level cancer phenotypes to single-cell transcriptomes re-mains challenging due to limited cell-level labels. Here, the authors develop scTransMIL, a transformer-based multi-instance learning framework that identifies cancer states, cancer subtypes, and potential cancer biomarkers with good performance across datasets.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: